John B. Kurek

903 total citations
18 papers, 720 citations indexed

About

John B. Kurek is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, John B. Kurek has authored 18 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in John B. Kurek's work include Reproductive System and Pregnancy (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Neurogenetic and Muscular Disorders Research (4 papers). John B. Kurek is often cited by papers focused on Reproductive System and Pregnancy (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Neurogenetic and Muscular Disorders Research (4 papers). John B. Kurek collaborates with scholars based in Australia, United States and Czechia. John B. Kurek's co-authors include Mark Murphy, Lawrence Austin, Surindar S. Cheema, L. Austin, Perry F. Bartlett, George Kannourakis, Sara Nouri, Frank Köentgen, Margarita Romanella and Michael Brendel and has published in prestigious journals such as Journal of Applied Physics, Brain Research and Journal of the Neurological Sciences.

In The Last Decade

John B. Kurek

17 papers receiving 688 citations

Peers

John B. Kurek
Mibel Pabon United States
Wolf‐Rüdiger Schäbitz Germany
Halina Jędrzejowska–Szypułka Poland
Friederike Knerlich‐Lukoschus Germany
Kinshi Kato Japan
Shinobu Shimizu Japan
Sheng Tan China
Domenico La Torre Italy
Wayne Tsang United States
Thomas M. Fandel United States
Mibel Pabon United States
John B. Kurek
Citations per year, relative to John B. Kurek John B. Kurek (= 1×) peers Mibel Pabon

Countries citing papers authored by John B. Kurek

Since Specialization
Citations

This map shows the geographic impact of John B. Kurek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Kurek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Kurek more than expected).

Fields of papers citing papers by John B. Kurek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John B. Kurek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Kurek. The network helps show where John B. Kurek may publish in the future.

Co-authorship network of co-authors of John B. Kurek

This figure shows the co-authorship network connecting the top 25 collaborators of John B. Kurek. A scholar is included among the top collaborators of John B. Kurek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John B. Kurek. John B. Kurek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Saravay, Stephen M., Michael D. Kaplowitz, John B. Kurek, et al.. (2004). How Do Delirium and Dementia Increase Length of Stay of Elderly General Medical Inpatients?. Psychosomatics. 45(3). 235–242. 88 indexed citations
3.
Azari, Michael F., Elizabeth C. Lopes, Bradley J. Turner, et al.. (2003). Behavioural and anatomical effects of systemically administered leukemia inhibitory factor in the SOD1G93A G1H mouse model of familial amyotrophic lateral sclerosis. Brain Research. 982(1). 92–97. 30 indexed citations
4.
Feeney, Sandra J., et al.. (2003). The effect of leukaemia inhibitory factor on SOD1 G93A murine amyotrophic lateral sclerosis. Cytokine. 23(4-5). 108–118. 18 indexed citations
5.
6.
White, Jason D., et al.. (2001). Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation. Muscle & Nerve. 24(5). 695–697. 26 indexed citations
7.
Boyle, Frances, et al.. (2001). The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatin. Cancer Chemotherapy and Pharmacology. 48(6). 429–434. 18 indexed citations
8.
Azari, Michael F., Adam Galle, Elizabeth C. Lopes, John B. Kurek, & Surindar S. Cheema. (2001). Leukemia inhibitory factor by systemic administration rescues spinal motor neurons in the SOD1 G93A murine model of familial amyotrophic lateral sclerosis. Brain Research. 922(1). 144–147. 28 indexed citations
9.
Kurek, John B.. (2000). AM424: History Of A Novel Drug Candidate. Clinical and Experimental Pharmacology and Physiology. 27(7). 553–557. 16 indexed citations
10.
Nash, Andrew D., John B. Kurek, & Douglas J. Hilton. (1999). Cytokines: From the laboratory to the clinic. Drug Development Research. 46(3-4). 197–205. 5 indexed citations
11.
Kurek, John B., et al.. (1998). LIF (AM424), a promising growth factor for the treatment of ALS. Journal of the Neurological Sciences. 160. S106–S113. 37 indexed citations
12.
Kurek, John B., et al.. (1998). Leukaemia inhibitory factor (LIF) production in a mouse model of spinal trauma. Neuroscience Letters. 249(1). 1–4. 43 indexed citations
13.
Austin, L., et al.. (1997). Controlled Release of Leukaemia Inhibitory Factor (LIF) to Tissues. Growth Factors. 15(1). 61–68. 25 indexed citations
14.
Kurek, John B., et al.. (1997). The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle & Nerve. 20(7). 815–822. 115 indexed citations
15.
Kurek, John B., et al.. (1997). The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle & Nerve. 20(7). 815–822. 4 indexed citations
16.
Kurek, John B., L. Austin, Surindar S. Cheema, Perry F. Bartlett, & Mark Murphy. (1996). Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation. Neuromuscular Disorders. 6(2). 105–114. 132 indexed citations
17.
Kurek, John B., Sara Nouri, George Kannourakis, Mark Murphy, & Lawrence Austin. (1996). Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle & Nerve. 19(10). 1291–1301. 127 indexed citations
18.
Kurek, John B., Sara Nouri, George Kannourakis, Mark Murphy, & Lawrence Austin. (1996). Leukemia inhibitory factor and interleukin‐6 are produced by diseased and regenerating skeletal muscle. Muscle & Nerve. 19(10). 1291–1301. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mibel Pabon Breakdown of academic impact, for papers by Wolf‐Rüdiger Schäbitz Breakdown of academic impact, for papers by Halina Jędrzejowska–Szypułka Breakdown of academic impact, for papers by Friederike Knerlich‐Lukoschus Breakdown of academic impact, for papers by Kinshi Kato Breakdown of academic impact, for papers by Shinobu Shimizu Breakdown of academic impact, for papers by Sheng Tan Breakdown of academic impact, for papers by Domenico La Torre Breakdown of academic impact, for papers by Wayne Tsang Breakdown of academic impact, for papers by Thomas M. Fandel
Rankless by CCL
2026